This study is to observe the prescription patterns and clinical efficacy of patientsprescribed with Tenero Tab/Tenero M SR Tab for diabetes treatment in routine clinicalpractice.
This study is to observe the clinical efficacy by analyzing the prescription patterns in
routine clinical practice and changes in HbA1c, FPG, PP2G, etc., of patients prescribed
with Tenero Tab/Tenero M SR Tab for diabetes treatment. Additionally, the study intends
to assess patient satisfaction based on these observations.
Inclusion Criteria:
1. Adults over 19 years of age
2. Individuals diagnosed with type 2 diabetes.
3. Individuals who, at the clinical discretion, are prescribed Tenero Tab or Tenero M
SR Tab for the purpose of diabetes treatment for the first time.
4. Individuals who have voluntarily provided written consent to participate in this
study.
Exclusion Criteria:
1. Pregnant or breastfeeding women.
2. Individuals who are contraindicated according to the approved indications of Tenero
Tab/Tenero M SR Tab.
3. Other cases where the principal investigator and study personnel deem individuals
ineligible for participation in this clinical trial.
Cheonan Endo Medical Clinic
Cheonan, Korea, Republic of
Investigator: Seokgi Yoon
Contact: 82-41-592-7201
Yeonhwa Kim
82-2-3489-6163
yh@hanlim.com
Seokgi Yoon, Principal Investigator
CHEONAN ENDO MEDICAL CLINIC